Nanosonics Ltd

NAN: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|Y%tNV%!LOCK|!!KTtLOCK|$j#R>c>

Nanosonics: Shares Undervalued as Headwinds Are Largely Temporary

We think recent earnings headwinds such as hospital budgetary constraints, abnormally low ultrasound procedural volumes, and investment for Nanosonics’ pipeline product are largely temporary, and forecast EBIT to grow at a five-year compound annual growth rate of 51% to AUD 67 million by fiscal 2029. We maintain our AUD 4 per share fair value and earnings estimates for narrow-moat Nanosonics. Shares in Nanosonics have declined roughly 20% since October 2024 and currently trade at roughly a 25% discount to our unchanged fair value estimate.

Sponsor Center